Biotech
This Week’s Catalyst Calendar Summary – 3/4/12
5 March 2012 – 12:16 am PDT
Comments Off
New China Pharma Rebound Trade for Mike
3 March 2012 – 12:16 am PDT
Comments Off
$ARRY Multiple Clinical Catalysts from Diverse Cancer Drug Pipeline Expected in 2012
29 February 2012 – 12:16 am PDT
Comments Off
Written by Mike Havrilla — Array BioPharma (NASDAQ:ARRY) is a small-cap, development stage biotech with several early to mid stage anti-cancer and anti-inflammatory compounds being evaluated in ongoing clinical trials, which are summarized below.
Continue reading...$CLDX Small-Cap Cancer Biotech with a Large Clinical Stage Pipeline
28 February 2012 – 12:16 am PDT
Comments Off
Written by Mike Havrilla — Celldex Therapeutics (NASDAQ:CLDX) is developing antibody-based immunotherapy treatments for cancer based on its Precision Targeted Immunotherapy Platform.
Continue reading...
7 March 2012 – 12:16 am PDT
Comments Off